First Time Loading...
L

LegoChem Biosciences Inc
KOSDAQ:141080

Watchlist Manager
LegoChem Biosciences Inc
KOSDAQ:141080
Watchlist
Price: 63 700 KRW -0.93% Market Closed
Updated: Jun 1, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
LegoChem Biosciences Inc

Wall Street analysts forecast LegoChem Biosciences Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LegoChem Biosciences Inc is 102 000 KRW with a low forecast of 101 000 KRW and a high forecast of 105 000 KRW.

Lowest Forecast
Wall Street Target
101 000 KRW
59% Upside
Average Forecast
Wall Street Target
102 000 KRW
60% Upside
Highest Forecast
Wall Street Target
105 000 KRW
65% Upside
Lowest
Price Target
101 000 KRW
59% Upside
Average
Price Target
102 000 KRW
60% Upside
Highest
Price Target
105 000 KRW
65% Upside
LegoChem Biosciences Inc Competitors:
Price Targets
4133
Abnova Taiwan Corp
205% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
43% Upside
SFZN
Siegfried Holding AG
14% Upside
SKAN
SKAN Group AG
21% Upside
4133
Abnova Taiwan Corp
205% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
43% Upside
SFZN
Siegfried Holding AG
14% Upside
SKAN
SKAN Group AG
21% Upside
GSS
Genetic Signatures Ltd
5% Upside
Q
QSI
Quantum-Si Inc
85% Upside
4YL
Nanoform Finland Oyj
98% Upside
TECH
Bio-Techne Corp
10% Upside

Revenue
Forecast

Revenue Estimate
LegoChem Biosciences Inc

For the last 8 years the compound annual growth rate for LegoChem Biosciences Inc's revenue is 45%. The projected CAGR for the next 3 years is 78%.

45%
Past Growth
78%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
LegoChem Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
46%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
LegoChem Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LegoChem Biosciences Inc's stock price target?
Price Target
102 000 KRW

According to Wall Street analysts, the average 1-year price target for LegoChem Biosciences Inc is 102 000 KRW with a low forecast of 101 000 KRW and a high forecast of 105 000 KRW.

What is LegoChem Biosciences Inc's Revenue forecast?
Projected CAGR
78%

For the last 8 years the compound annual growth rate for LegoChem Biosciences Inc's revenue is 45%. The projected CAGR for the next 3 years is 78%.

ALPHA SPREAD
Join more than 142,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.